Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Receivables (2016 - 2025)

Ptc Therapeutics has reported Receivables over the past 13 years, most recently at $181.6 million for Q4 2025.

  • Quarterly results put Receivables at $181.6 million for Q4 2025, up 14.55% from a year ago — trailing twelve months through Dec 2025 was $181.6 million (up 14.55% YoY), and the annual figure for FY2025 was $181.6 million, up 14.55%.
  • Receivables for Q4 2025 was $181.6 million at Ptc Therapeutics, down from $203.1 million in the prior quarter.
  • Over the last five years, Receivables for PTCT hit a ceiling of $210.5 million in Q1 2025 and a floor of $78.8 million in Q2 2021.
  • Median Receivables over the past 5 years was $164.1 million (2023), compared with a mean of $159.0 million.
  • Biggest five-year swings in Receivables: soared 78.86% in 2021 and later dropped 1.69% in 2024.
  • Ptc Therapeutics' Receivables stood at $110.5 million in 2021, then surged by 40.88% to $155.6 million in 2022, then increased by 3.48% to $161.0 million in 2023, then fell by 1.53% to $158.6 million in 2024, then increased by 14.55% to $181.6 million in 2025.
  • The last three reported values for Receivables were $181.6 million (Q4 2025), $203.1 million (Q3 2025), and $196.1 million (Q2 2025) per Business Quant data.